Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hegele

Showing results (71-80 of 1,071) with videos related to

Pageof 108
Sort By:
Trends in Cardiovascular Medicine|June 5, 2004
Phenomics, lipodystrophy, and the metabolic syndromeRobert A Hegele
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 15, 1991
The molecular basis of hepatic lipase deficiencyR A Hegele
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 15, 1992
The patient as interface between genes and the environmentR A Hegele
Arteriosclerosis, Thrombosis, and Vascular Biology|February 18, 2006
Gene therapy with lipoprotein lipase variant S447XRobert A Hegele
Journal of the American College of Cardiology|January 20, 2018
Learning From Patients With Ultrarare Conditions: Cholesterol Hoof BeatsRobert A Hegele
The Lancet. Diabetes & Endocrinology|September 8, 2022
PCSK9 inhibition in children with familial hypercholesterolaemiaRobert A Hegele
Atherosclerosis|October 9, 2023
Illuminating the full spectrum of APOE variationRobert A Hegele
European Heart Journal|February 17, 2022
Apolipoprotein C-III inhibition to lower triglycerides: one ring to rule them all?Robert A Hegele
Critical Reviews in Clinical Laboratory Sciences|August 1, 1997
Candidate genes, small effects, and the prediction of atherosclerosisR A Hegele
European Heart Journal|May 10, 2023
Apolipoprotein C-II: a new look at an old proteinRobert A Hegele
Pageof 108

Showing results (71-80 of 1,071) with videos related to

Sort By:
Pageof 108
Trends in Cardiovascular Medicine|June 5, 2004
Phenomics, lipodystrophy, and the metabolic syndromeRobert A Hegele
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 15, 1991
The molecular basis of hepatic lipase deficiencyR A Hegele
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 15, 1992
The patient as interface between genes and the environmentR A Hegele
Arteriosclerosis, Thrombosis, and Vascular Biology|February 18, 2006
Gene therapy with lipoprotein lipase variant S447XRobert A Hegele
Journal of the American College of Cardiology|January 20, 2018
Learning From Patients With Ultrarare Conditions: Cholesterol Hoof BeatsRobert A Hegele
The Lancet. Diabetes & Endocrinology|September 8, 2022
PCSK9 inhibition in children with familial hypercholesterolaemiaRobert A Hegele
Atherosclerosis|October 9, 2023
Illuminating the full spectrum of APOE variationRobert A Hegele
European Heart Journal|February 17, 2022
Apolipoprotein C-III inhibition to lower triglycerides: one ring to rule them all?Robert A Hegele
Critical Reviews in Clinical Laboratory Sciences|August 1, 1997
Candidate genes, small effects, and the prediction of atherosclerosisR A Hegele
European Heart Journal|May 10, 2023
Apolipoprotein C-II: a new look at an old proteinRobert A Hegele
Pageof 108